E, in secondo luogo, aumenta la sua biodisponibilit
Not clean
Combining with DPP-4 inhibitors is generally not recommended, as both drug classes work on the incretin system Adding basal insulin for those with more significant hyperglycaemia, which can be used alongside GLP-1 medications (with careful monitoring for hypoglycaemia) Switching to insulin therapy entirely may be necessary for those with advanced beta cell failure For weight management , when GLP-1 medications don't produce adequate weight loss, alternatives include: Orlistat , a lipase inhibitor that reduces fat absorption, though weight loss is typically modest (2-3 kg on average) Naltrexone-bupropion (Mysimba), which works on appetite centres through different pathways
In a trial of 411 adults with type 2 diabetes that tested different doses of the pill, participants taking a high dose lost an average of around 10 pounds over four months, compared to those who received a placebo
Side Effects : Similar to oral semaglutide, injectable formulations may cause gastrointestinal side effects